Delivery Order SPE2DB22D3004-SPE2DB24FRP10
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,237.40, is for the delivery of the medication Qulipta 60 mg tablets. This is a firm fixed-price delivery order contract, with an ultimate completion date of January 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), to provide the pharmaceutical product Qulipta 30 MG Tablet 30S. The award is a firm fixed price delivery order with a ceiling value of $1,116.21 and an ultimate completion date of April 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.14, is for the supply of Qulipta 30 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order, with a performance period through February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Qulipta 60 mg tablets. The contract has a ceiling value of $3,063.02 and is a firm fixed-price delivery order contract with a period of performance through July 10, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,116.21, is for the delivery of the pharmaceutical product Qulipta 30 mg Tablet 30s. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 6, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,353.23 delivery order contract is for the supply of Qulipta 30 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a delivery order issued against the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp for the pharmaceutical product Qulipta 60 mg tablet (National Drug Code 4565406315). The $1,116.21 firm-fixed-price order has an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this critical medication to support military treatment programs and facilities worldwide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,488.28, is for the delivery of a prescription medication, Qulipta 30 mg tablet, with an ultimate completion date of April 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The DO is for the supply of Qulipta 60 mg Tablets, a specialty pharmaceutical medication, with a ceiling value of $7,895.74 and an ultimate completion date of September 27, 2024. The contract is a Firm Fixed Price (FFP) arrangement with no set-aside designation....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver Qulipta 60 mg tablets. The contract, valued at $1,633.95, is a delivery order and has a firm fixed price. The award is not set aside for any specific business category. The contract supports the DLA's mission of providing medical supplies and pharmaceuticals to military treatment facilities, veterans' hospitals, and other federal healthcare...